Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.760
-0.120 (-4.17%)
At close: Jul 14, 2026, 4:00 PM EDT
2.897
+0.137 (4.95%)
After-hours: Jul 14, 2026, 6:27 PM EDT
Equillium Market Cap
Equillium has a market cap or net worth of $174.51 million as of July 14, 2026. Its market cap has increased by 1,475.95% in one year.
Market Cap
174.51M
Enterprise Value
118.30M
1-Year Change
1,475.95%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $174.51M, a decrease of -25.60%. That is a compound annual growth rate of -3.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 174.51M | 84.89% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 197.00M |
| Korro Bio | 193.26M |
| Acumen Pharmaceuticals | 192.13M |
| Arcturus Therapeutics Holdings | 188.73M |
| Humacyte | 183.79M |
| Outlook Therapeutics | 183.71M |
| MediWound | 183.27M |
| Tenaya Therapeutics | 183.23M |